The global ophthalmic packaging market size accounted for USD 7.35 billion in 2024, grew to USD 7.93 billion in 2025 and is projected to surpass around USD 15.89 billion by 2034, representing a healthy CAGR of 8.20% between 2024 and 2034. The North America ophthalmic packaging market size is calculated at USD 2.70 billion in 2024 and is expected to grow at a fastest CAGR of 7.80% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Ophthalmic Packaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Ophthalmic Packaging Market Revenue and Volume, by Material, 2024-2034
8.1.1 Plastic
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Metal
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Glass
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Ophthalmic Packaging Market Revenue and Volume, by Product Type, 2024-2034
9.1.1. Bottles & Vials
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Blister Packs
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Ampoules
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Squeezable Tubes
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Ophthalmic Packaging Market Revenue and Volume, by Application, 2024-2034
10.1.1. Prescription Medication
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. OTC Products
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Medical Devices
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Material (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Product Type (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1. Amcor
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. West Pharmaceutical Services, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Gerresheimer AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. SCHOTT AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. AptarGroup, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Akorn, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Johnson & Johnson Vision
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Mitotech, SA
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bausch & Lomb Incorporated
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. AERIE PHARMACEUTICALS, INC.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample